Search Results 531-540 of 17392 for bisphosphonates side effects

  1. Cardiovascular Medicine - Clinical trials

    A standard treatment is considered not well tolerated if the patient experiences severe side effects without providing an acceptable level of clinical benefit.

  2. Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

  3. Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

  4. Study of Radium-223 Dichloride Versus Placebo and Treatment With Exemestane / Everolimus in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

  5. Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer - Mayo Clinic

    This phase II trial studies the side effects of durvalumab and tremelimumab and to see how well they work with or without high or low-dose radiation therapy ...

  6. Low hemoglobin count When to see a doctor - Mayo Clinic

    Anemia (low red blood cell counts). American Cancer Society. https://www.cancer.org/cancer/managing-cancer/side-effects/low-blood-counts/anemia.

  7. SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing’s Syndrome - Mayo Clinic

    The study's secondary goal is to assess SPI-62's safety and side effects, if any. Additionally, the study will look at the possible effect of SPI-62 on ...

  8. Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Subjects With Hypoparathyroidism - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. ... 6 months: fluoride tablets, oral bisphosphonates ... 12 months: intravenous bisphosphonates, drug or alcohol ...

  9. Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

  10. Chronic Lymphocytic Clinical Trials

    This phase II trial studies the side effects and how well ibrutinib works in treating patients with chronic lymphocytic leukemia who responded to initial ...